Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Net cash used in operating activities	$ (384,027)	$ (199,737)
Cash from investing activities:
Patent expenditures	(4,074)	(2,448)
Net cash used in investing activities	(4,074)	(2,448)
Cash from financing activities:
Proceeds from notes payable-convertible net		103,000
Proceeds from issuance of note payable related party	445,584	70,000
Payments on notes payable related party	(10,000)
Payments on notes payable	(70,000)
Proceeds from sale of convertible preferred stock	20,000	18,000
Proceeds from sale of common stock		8,000
Net cash provided by financing activities	385,584	199,000
Net change in cash	(2,517)	(3,185)
Cash and cash equivalents at beginning of period	2,819	4,332
Cash and cash equivalents at end of period	302	1,147
Supplemental disclosure of cash flow information
Cash paid for interest	4,654	1,128
Cash paid for income taxes		0
Non-Cash Transactions
Common stock issued for convertible debt	74,091
Reclassification of derivative liability to permanent equity	17,035
Forgiveness of accrued salaries	278,259
Discount of convertible notes payable		103,000
Preferred Stock Issued For Notes Payable Related Party And Interest [Member]
Non-Cash Transactions
Preferred Stock Issued	110,300
Preferred Stock Issued For Accrued Dividends And Interest [Member]
Non-Cash Transactions
Preferred Stock Issued	$ 23,578